rs765249233
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The ENST00000221249.10(PNPLA6):āc.2T>Cā(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000281 in 1,603,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 32)
Exomes š: 0.000029 ( 0 hom. )
Consequence
PNPLA6
ENST00000221249.10 start_lost
ENST00000221249.10 start_lost
Scores
2
5
9
Clinical Significance
Conservation
PhyloP100: 0.610
Genes affected
PNPLA6 (HGNC:16268): (patatin like phospholipase domain containing 6) This gene encodes a phospholipase that deacetylates intracellular phosphatidylcholine to produce glycerophosphocholine. It is thought to function in neurite outgrowth and process elongation during neuronal differentiation. The protein is anchored to the cytoplasmic face of the endoplasmic reticulum in both neurons and non-neuronal cells. Mutations in this gene result in autosomal recessive spastic paraplegia, and the protein is the target for neurodegeneration induced by organophosphorus compounds and chemical warfare agents. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PNPLA6 | NM_001166111.2 | c.2T>C | p.Met1? | start_lost | 2/34 | NP_001159583.1 | ||
PNPLA6 | NM_001166113.1 | c.2T>C | p.Met1? | start_lost | 3/35 | NP_001159585.1 | ||
PNPLA6 | NM_006702.5 | c.2T>C | p.Met1? | start_lost | 3/35 | NP_006693.3 | ||
PNPLA6 | NM_001166112.2 | c.2T>C | p.Met1? | start_lost | 3/34 | NP_001159584.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PNPLA6 | ENST00000221249.10 | c.2T>C | p.Met1? | start_lost | 3/35 | 1 | ENSP00000221249 | A1 | ||
PNPLA6 | ENST00000450331.7 | c.2T>C | p.Met1? | start_lost | 3/35 | 1 | ENSP00000394348 | A1 | ||
PNPLA6 | ENST00000414982.7 | c.2T>C | p.Met1? | start_lost | 2/34 | 2 | ENSP00000407509 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000954 AC: 22AN: 230514Hom.: 0 AF XY: 0.0000481 AC XY: 6AN XY: 124762
GnomAD3 exomes
AF:
AC:
22
AN:
230514
Hom.:
AF XY:
AC XY:
6
AN XY:
124762
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000289 AC: 42AN: 1451796Hom.: 0 Cov.: 31 AF XY: 0.0000277 AC XY: 20AN XY: 721052
GnomAD4 exome
AF:
AC:
42
AN:
1451796
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
721052
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152128Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74306
GnomAD4 genome
AF:
AC:
3
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74306
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 01, 2018 | Initiation codon variant in a gene for which loss-of-function is a known mechanism of disease; however, a nearby downstream Methionine could be used as an alternative initiation codon; Has not been previously published as pathogenic or benign to our knowledge - |
Hereditary spastic paraplegia 39 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change affects the initiator methionine of the PNPLA6 mRNA. The next in-frame methionine is located at codon 9. This variant is present in population databases (rs765249233, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with PNPLA6-related conditions. ClinVar contains an entry for this variant (Variation ID: 240695). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.;.;T;.;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D;D;D;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
N;N;N;N
PROVEAN
Benign
N;.;.;N;.;N;N;.;.
REVEL
Benign
Sift
Uncertain
D;.;.;D;.;D;D;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D
Polyphen
B;.;.;.;.;.;B;.;.
Vest4
MutPred
Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);Gain of glycosylation at M1 (P = 0.0049);
MVP
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at